Clinical Trial Update: Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating sintilimab in combination with gemcitabine and platinum chemotherapy as first-line therapy for advanced or metastatic squamous non-sm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Non-small Cell Lung Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Platinum-based chemotherapy (platinum-based chemotherapy)
• Sintilimab (sintilimab)

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Squamous NSCLC | Phase 3 | Status: COMPLETED | Results posted: 2021-04-01